Jefferies Upgrades Vanda Pharmaceuticals (VNDA) to Buy; Giving Credit for Tasimelteon

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 7/14/2026

1. IBM
2. JPM
3. TREX
4. BAC
5. SPY
6. WFC
7. ERAS
8. SPCX
9. SPRO
10. TSCO

Go back to Jefferies Upgrades Vanda Pharmaceuticals (VNDA) to Buy; Giving Credit for Tasimelteon

Vanda Pharmaceuticals (VNDA) Misses Q4 EPS by 1c

February 12, 2013 7:31 AM EST

Vanda Pharmaceuticals, Inc. (NASDAQ: VNDA) reported Q4 EPS of ($0.23), $0.01 worse than the analyst estimate of ($0.22). Revenue for the quarter came in at $7.9 million versus the consensus estimate of $8.6 million.

For earnings history and earnings-related data on Vanda Pharmaceuticals, Inc. (VNDA) click here.... More